FIGURE 3.
Curve showing PFS (a) and OS (b) according to post‐treatment PS after carboplatin plus etoposide therapy among the pretreatment PS ≥3 group (N = 25). OS, overall survival; PFS, progression‐free survival; PS, performance status
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.